Dr Reddys Laboratories (RDY) Change in Account Payables (2009 - 2026)

Dr Reddys Laboratories has reported Change in Account Payables for 17 years, with the latest figure at $45.3 million in Q2 2026.

• On a quarterly basis, Change in Account Payables fell 37.57% year-over-year to $45.3 million in Q2 2026; TTM through Jun 2026 was $166.9 million, a 61.98% increase from a year earlier, with the FY2026 full-year figure at $30.0 million, up 650.0% from the prior year.
• Change in Account Payables was $45.3 million for Q2 2026 at Dr Reddys Laboratories, up from $30.3 million in the prior quarter.
• The five-year high for Change in Account Payables was $72.5 million in Q2 2025, with the low at -$22.9 million in Q3 2022.
• Average Change in Account Payables over 5 years is $17.9 million, with a median of $23.0 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Change in Account Payables tumbled 1251.9% in 2022, then soared 490.89% in 2023.
• Over 5 years, Change in Account Payables stood at $33.7 million in 2022, then tumbled by 86.08% to $4.7 million in 2023, then jumped by 303.52% to $18.9 million in 2024, then soared by 60.32% to $30.3 million in 2025, then jumped by 49.34% to $45.3 million in 2026.
• The last three Change in Account Payables figures came in at $45.3 million (Q2 2026), $30.3 million (Q3 2025), and $72.5 million (Q2 2025), per Business Quant data.